Biocon stocks attract attention as Mylan, owned by Viatris, prepares to sell its stake through a block transaction: Sources
Mylan, a subsidiary of Viatris, is planning to divest a portion of its 5.64% stake in Biocon Ltd via a block deal, as per insider information.…
